ABACAVIR, LAMIVUDINE AND ZIDOVUDINE 300 mg/1
ABACAVIR , LAMIVUDINE AND ZIDOVUDINE · TABLET · Lupin Pharmaceuticals, Inc.
ABACAVIR, LAMIVUDINE AND ZIDOVUDINE is a tablet containing abacavir , lamivudine and zidovudine at 300 mg/1, taken oral. Manufactured by Lupin Pharmaceuticals, Inc..
Key Facts
- Brand Name
- ABACAVIR, LAMIVUDINE AND ZIDOVUDINE
- Generic Name
- ABACAVIR , LAMIVUDINE AND ZIDOVUDINE
- NDC Code (Product)
68180-286- Manufacturer
- Lupin Pharmaceuticals, Inc.
- Strength
- 300 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- ANDA202912
- Drug Class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Marketing Start
- 12/17/2013
Recall History
No Recall HistoryFrequently Asked Questions
What is ABACAVIR, LAMIVUDINE AND ZIDOVUDINE used for?
ABACAVIR, LAMIVUDINE AND ZIDOVUDINE contains ABACAVIR , LAMIVUDINE AND ZIDOVUDINE. It is a tablet taken oral. Consult your doctor for specific uses.
Is ABACAVIR, LAMIVUDINE AND ZIDOVUDINE a controlled substance?
ABACAVIR, LAMIVUDINE AND ZIDOVUDINE is not classified as a controlled substance by the DEA.
What is the generic name for ABACAVIR, LAMIVUDINE AND ZIDOVUDINE?
The generic name for ABACAVIR, LAMIVUDINE AND ZIDOVUDINE is ABACAVIR , LAMIVUDINE AND ZIDOVUDINE. There are no other listed brand versions of ABACAVIR , LAMIVUDINE AND ZIDOVUDINE.
What is the NDC code for ABACAVIR, LAMIVUDINE AND ZIDOVUDINE 300 mg/1?
The NDC (National Drug Code) for ABACAVIR, LAMIVUDINE AND ZIDOVUDINE 300 mg/1 is 68180-286, listed by Lupin Pharmaceuticals, Inc..
Product NDC
68180-286
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)